Free Trial

The Biotech Growth Trust (LON:BIOG) Stock Price Passes Below 50 Day Moving Average - Should You Sell?

The Biotech Growth Trust logo with Financial Services background

Shares of The Biotech Growth Trust PLC (LON:BIOG - Get Free Report) passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 766.89 ($10.16) and traded as low as GBX 669.96 ($8.88). The Biotech Growth Trust shares last traded at GBX 684 ($9.06), with a volume of 107,467 shares trading hands.

The Biotech Growth Trust Stock Performance

The company has a fifty day moving average price of GBX 753.45 and a two-hundred day moving average price of GBX 867.92. The company has a debt-to-equity ratio of 11.02, a current ratio of 0.59 and a quick ratio of 0.00. The company has a market capitalization of £199.41 million, a P/E ratio of 2.34 and a beta of 0.50.

The Biotech Growth Trust Company Profile

(Get Free Report)

The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

Recommended Stories

Should You Invest $1,000 in The Biotech Growth Trust Right Now?

Before you consider The Biotech Growth Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Biotech Growth Trust wasn't on the list.

While The Biotech Growth Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines